Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Neoplasms 20 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 8 Neoplasm Metastasis 7 Lymphoma 7 Lung Neoplasms 7 Hematologic Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leukemia 5 Fatigue 5 Stomach Neoplasms 4 Depression 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pain 3 Myelodysplastic Syndromes 3 Motor Activity 3 Melanoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3

Interventions

peppermint oil 1 bismuth tripotassium dicitrate 1 S 1 (combination) 1 Palliative Care 1 Oxaliplatin 1 Omeprazole 1 Clarithromycin 1 Aromatherapy 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy Effect × Palliative Care × Clear all

NCT05649852 2026-01-15

PASITHEA

GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase NA Recruiting

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon ⚡